Sugaflo 10 Tablet 15

Lloyd Healthcare Pvt.ltd

Strip of 15 Units

MRP ₹247.50

₹198.00

₹16.50/Units

20% off
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

Strength:

About Sugaflo 10 Tablet 15

Sugaflo 10 Tablet is primarily used to manage Type 2 diabetes mellitus. It belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

In addition to controlling high blood sugar levels, this medicine has also been approved for reducing the risk of certain health conditions. These include sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalisation due to heart failure in adults with chronic kidney disease. this medicine is also used to minimise the risk of major adverse cardiovascular events in adults with Type 2 diabetes and established cardiovascular disease.

Before you start taking this medicine, it's important to consult your doctor for the appropriate dosage and frequency. You should also inform your doctor about any pre-existing conditions or ongoing medications. If you notice any side effects while on this medicine, notify your doctor immediately. Make sure to continue taking the medicine for the duration prescribed by your doctor for optimal results.

Last Updated On 23 Dec. 2024 | 10:53AM (IST)

Certified Content

Written by

Dr Nikita Lobo
Dr Nikita Lobo
Medical Editor & Reviewer | 7 years

BDS, MDS

Reviewed by

Dr. Osama Ahmed
Dr. Osama Ahmed
Dental/Medical Writer, Editor, Reviewer | 3 years

Bachelor of Dental Surgery

Check out Editorial Policy

Manufacturer details

702, Balaji Buisness Park, Andheri Kurla Road, Marol Naka, Andheri East, Mumbai, Maharashtra 400059

Country of origin: INDIA

References

  • U.S. National Library of Medicine. (2022). Dapagliflozin. MedlinePlus. Retrieved 1 April 2024, from https://medlineplus.gov/druginfo/meds/a614015.html

  • U.S. Food and Drug Administration. (2022). Drug Approval Package: Farxiga (dapagliflozin) Tablets. U.S. Department of Health and Human Services. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s026lbl.pdf

  • Dhillon S. (2019). Dapagliflozin: A Review in Type 2 Diabetes. Drugs, 79(10), 1135–1146. https://doi.org/10.1007/s40265-019-01148-3

  • Chertow, G. M., Vart, P., Jongs, N., Toto, R. D., Gorriz, J. L., Hou, F. F., McMurray, J. J. V., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Stefánsson, B. V., Langkilde, A. M., Wheeler, D. C., Heerspink, H. J. L., & DAPA-CKD Trial Committees and Investigators (2021). Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease. Journal of the American Society of Nephrology : JASN, 32(9), 2352–2361. https://doi.org/10.1681/ASN.2021020167

  • Cox, Z. L., Collins, S. P., Hernandez, G. A., McRae, A. T., 3rd, Davidson, B. T., Adams, K., Aaron, M., Cunningham, L., Jenkins, C. A., Lindsell, C. J., Harrell, F. E., Jr, Kampe, C., Miller, K. F., Stubblefield, W. B., & Lindenfeld, J. (2024). Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure. Journal of the American College of Cardiology, 83(14), 1295–1306. https://doi.org/10.1016/j.jacc.2024.02.009

  • National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 9887712, Dapagliflozin. Retrieved November 15, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Dapagliflozin.

Was this product description useful?
22 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Recommended Substitute

50.1% CHEAPER

Dapanux 10 Tablet 10
Dapanux 10 Tablet 10

Nicholas Healthcare Limited

Strip of 10 Units

₹82.33

₹8.23/Units

userBought

30170 users bought this instead

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Registered Office Address

Intellihealth Solutions Private Limited

Office Unit no. 1, 2, 5, & 7, 6th floor Urmi Corporate Park Solaris, Saki Vihar Rd, Opp. L&T Flyover, New Mhada Colony, Budhia Jadhav Wadi, Mumbai, Maharashtra 400072.
CIN: U85320MH2019PTC320566
Telephone:09240250346

Grievance Officer

Name: Chandrasekhar Swaminathan

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.5.11

copyright2025 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner